Europe's Opportunity: Personalizing Cancer Follow-Up with ctDNA MRD Testing

07 July 2026 by Bianca CUCOS (Centre for Innovation in Medicine)

What happens after cancer treatment is becoming an important question for personalised cancer care in Europe. For many patients, follow-up still means waiting for the next scan, the next appointment, or the next sign that something has changed. Through GUIDE.MRD, we are exploring how ctDNA-based...

Register to the Health Policy Platform

See full publication (Platform members only)